CirTran Corporation (CIRX) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist CirTran Corporation (CIRX) ein Industrials-Unternehmen mit einer Bewertung von 0. Bewertet mit 44/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 17. März 2026CirTran Corporation (CIRX) Industriebetrieb-Profil
CirTran Corporation, established in 1987, provides manufacturing, marketing, and distribution services for consumer products, including tobacco, medical devices, and beverages. Operating under the HUSTLER brand, the company offers a diverse portfolio, but faces challenges typical of OTC-listed entities with limited market capitalization and negative profitability.
Investmentthese
CirTran Corporation presents a speculative investment opportunity due to its presence in the consumer products market. However, several factors warrant caution. The company's negative P/E ratio of -0.06 and a profit margin of -150.2% indicate significant financial challenges. The company's small market capitalization makes it susceptible to volatility. Potential investors should carefully weigh these risks against any potential upside from successful brand partnerships or market expansion. The company's ability to improve its financial performance and achieve sustainable profitability is crucial for its long-term viability.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market Cap of $0.00B indicates a micro-cap company with limited market presence.
- P/E Ratio of -0.06 reflects negative earnings and potential financial distress.
- Profit Margin of -150.2% signals significant losses and operational inefficiencies.
- Gross Margin of 57.9% suggests potential in production efficiency, but is offset by high operating costs.
- Beta of -0.10 indicates low volatility relative to the market, but may also reflect lack of investor interest.
Wettbewerber & Vergleichsunternehmen
Staerken
- Established brand presence through the HUSTLER brand.
- Diversified product portfolio across tobacco, beverage, and medical device sectors.
- Manufacturing capabilities for a range of consumer products.
- Existing distribution network.
Schwaechen
- Small market capitalization and limited financial resources.
- Negative profitability and high debt levels.
- Dependence on the HUSTLER brand, which may have negative connotations.
- Limited scale of operations with only 4 employees.
Katalysatoren
- Ongoing: Expansion of the HUSTLER brand into new product categories, potentially increasing revenue streams.
- Ongoing: Strategic partnerships with other companies to expand distribution networks.
- Upcoming: Potential for new product launches in the beverage or medical device sectors.
- Upcoming: Securing licensing agreements for additional brands to diversify the product portfolio.
- Ongoing: Efforts to improve operational efficiency and reduce costs, potentially leading to improved profitability.
Risiken
- Ongoing: Intense competition from larger, more established players in the consumer goods industry.
- Potential: Changes in consumer preferences or regulatory requirements that could negatively impact demand for its products.
- Ongoing: Dependence on the HUSTLER brand, which may have negative connotations for some consumers.
- Potential: Economic downturns that could reduce consumer spending and impact sales.
- Ongoing: Financial instability due to negative profitability and limited access to capital.
Wachstumschancen
- Expansion of E-Cigarette and Vapor Products: The global e-cigarette and vapor market is projected to reach $82.7 billion by 2027, growing at a CAGR of 23.8%. CirTran, through its HUSTLER brand, can capitalize on this trend by introducing innovative products and expanding its distribution network. Success in this market could significantly boost revenue, but requires substantial investment in product development and marketing.
- Strategic Partnerships and Licensing Agreements: CirTran can pursue strategic partnerships with established brands or secure licensing agreements to expand its product portfolio and market reach. Collaborating with well-known brands can enhance the company's credibility and access to new markets. Successful partnerships could lead to increased sales and brand recognition, but require careful negotiation and alignment of interests.
- Geographic Expansion into Emerging Markets: Emerging markets offer significant growth opportunities for consumer goods companies. CirTran can explore expanding its distribution network into regions with growing disposable incomes and increasing demand for its products. Entering new markets requires careful market research, adaptation to local preferences, and compliance with local regulations. Success in emerging markets could diversify revenue streams and reduce reliance on mature markets.
- Development of Innovative Beverage Products: The global beverage market is constantly evolving, with consumers seeking new and innovative products. CirTran can invest in the development of unique and appealing beverage products to capture market share. This requires significant investment in research and development, as well as effective marketing and distribution strategies. Successful product innovation could lead to increased sales and brand loyalty.
- Focus on Medical Device Manufacturing: The medical device industry is experiencing steady growth, driven by an aging population and increasing healthcare spending. CirTran can leverage its manufacturing capabilities to produce medical devices for various applications. Entering the medical device market requires compliance with stringent regulatory requirements and significant investment in quality control and manufacturing processes. Success in this market could diversify revenue streams and enhance the company's reputation.
Chancen
- Expansion into emerging markets with growing consumer demand.
- Development of innovative products to capture market share.
- Strategic partnerships and licensing agreements with established brands.
- Growth in the e-cigarette and vapor product market.
Risiken
- Intense competition from larger, more established players.
- Changing consumer preferences and regulatory landscape.
- Brand-related risks associated with the HUSTLER brand.
- Economic downturns that could reduce consumer spending.
Wettbewerbsvorteile
- Brand recognition through the HUSTLER brand.
- Manufacturing capabilities for a diverse range of products.
- Established distribution network.
- Proprietary technology related to its product lines.
Ueber CIRX
CirTran Corporation, founded in 1987 and based in Las Vegas, Nevada, operates as a provider of manufacturing, marketing, distribution, and technology services for a diverse range of consumer products. The company's portfolio includes tobacco products, medical devices, and beverages, primarily marketed under the HUSTLER brand. Its product offerings encompass condoms, electronic cigarettes, electronic cigars, cigars, hookahs, hookah tobacco, energy drinks, and water beverages, along with related merchandise. CirTran focuses on delivering end-to-end solutions, from manufacturing to distribution, catering to a global market. The company's business model is centered on leveraging its manufacturing capabilities and brand partnerships to offer a variety of consumer goods. However, with a small team of four employees, its operational scale is limited, and the company faces challenges in competing with larger, more established players in the consumer goods market. Its negative profit margin reflects the difficulties in achieving profitability in a competitive landscape.
Was das Unternehmen tut
- Manufactures consumer products, including tobacco products, medical devices, and beverages.
- Markets and distributes products under the HUSTLER brand.
- Offers condoms, electronic cigarettes, and related merchandise.
- Provides electronic cigars, cigars, hookahs, and hookah tobacco.
- Produces energy drinks and water beverages.
- Offers technology services related to its product lines.
Geschaeftsmodell
- Manufacturing consumer products in-house or through contract manufacturers.
- Marketing and distributing products through various channels, including retail and online.
- Generating revenue through the sale of its branded products.
- Licensing its brand for use on other products.
Branchenkontext
CirTran Corporation operates within the competitive consumer goods industry, which includes tobacco, beverage, and medical device sectors. The industry is characterized by evolving consumer preferences, regulatory changes, and intense competition. The company's focus on the HUSTLER brand targets a specific consumer segment, but also exposes it to brand-related risks. The market for electronic cigarettes and energy drinks is growing, but is also subject to increasing regulatory scrutiny. CirTran's small size and limited resources make it challenging to compete with larger, more established players in the industry.
Wichtige Kunden
- Consumers of tobacco products, including smokers and vapers.
- Consumers of energy drinks and water beverages.
- Consumers of medical devices.
- Retailers and distributors who sell CirTran's products.
Finanzdaten
Chart & Info
CirTran Corporation (CIRX) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
-
Stocks That Hit 52-Week Lows On Tuesday
· 3. Dez. 2019
-
Stocks That Hit 52-Week Lows On Thursday
· 14. Nov. 2019
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer CIRX.
Kursziele
Wall-Street-Kurszielanalyse fuer CIRX.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von CIRX auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Klassifizierung
Branche ConglomeratesFuehrung: Iehab J. Hawatmeh
CEO
Iehab J. Hawatmeh serves as the CEO of CirTran Corporation, overseeing the company's manufacturing, marketing, distribution, and technology services. His leadership is focused on managing the company's diverse product portfolio, including tobacco products, medical devices, and beverages. With a small team, Hawatmeh is responsible for strategic decisions and operational efficiency. His background includes experience in managing consumer product companies and navigating competitive markets.
Erfolgsbilanz: Under Iehab J. Hawatmeh's leadership, CirTran Corporation has focused on maintaining its presence in the consumer products market. Key strategic decisions have involved managing the HUSTLER brand and adapting to changing consumer preferences. The company has faced challenges in achieving profitability and expanding its market share. Hawatmeh's tenure has been marked by efforts to streamline operations and explore new growth opportunities.
CIRX OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to less regulatory oversight. Investing in OTC Other stocks carries significant risks due to the potential for fraud, lack of liquidity, and limited transparency compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited Information: Lack of readily available financial information and regulatory oversight.
- Low Liquidity: Difficulty in buying or selling shares due to low trading volume.
- Price Volatility: Susceptibility to significant price swings due to limited market participation.
- Potential for Fraud: Increased risk of fraudulent activities due to less stringent listing requirements.
- Going Concern Risk: Uncertainty about the company's ability to continue operating due to financial difficulties.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team and their track record.
- Check for any regulatory actions or legal disputes.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- Operational History: The company has been in operation since 1987.
- Product Portfolio: Offers a range of consumer products under the HUSTLER brand.
- CEO Leadership: Has a named CEO in Iehab J. Hawatmeh.
- Corporate Structure: Has a registered office in Las Vegas, Nevada.
- Industry Sector: Operates in the Industrials sector.
CIRX Industrials Aktien-FAQ
What are the key factors to evaluate for CIRX?
CirTran Corporation (CIRX) currently holds an AI score of 44/100, indicating low score. Key strength: Established brand presence through the HUSTLER brand.. Primary risk to monitor: Ongoing: Intense competition from larger, more established players in the consumer goods industry.. This is not financial advice.
How frequently does CIRX data refresh on this page?
CIRX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CIRX's recent stock price performance?
Recent price movement in CirTran Corporation (CIRX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand presence through the HUSTLER brand.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CIRX overvalued or undervalued right now?
Determining whether CirTran Corporation (CIRX) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CIRX?
Before investing in CirTran Corporation (CIRX), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding CIRX to a portfolio?
Potential reasons to consider CirTran Corporation (CIRX) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Established brand presence through the HUSTLER brand.. Additionally: Diversified product portfolio across tobacco, beverage, and medical device sectors.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of CIRX?
Yes, most major brokerages offer fractional shares of CirTran Corporation (CIRX) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track CIRX's earnings and financial reports?
CirTran Corporation (CIRX) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for CIRX earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.
- OTC market stocks carry higher risk than exchange-listed stocks.